GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (NAS:CLLS) » Definitions » Cyclically Adjusted FCF per Share

CLLS (Cellectis) Cyclically Adjusted FCF per Share : $-1.62 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cellectis Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Cellectis's adjusted free cash flow per share for the three months ended in Dec. 2024 was $-0.018. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-1.62 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Cellectis was 2.40% per year. The lowest was 2.40% per year. And the median was 2.40% per year.

As of today (2025-05-11), Cellectis's current stock price is $1.58. Cellectis's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was $-1.62. Cellectis's Cyclically Adjusted Price-to-FCF of today is .


Cellectis Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Cellectis's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectis Cyclically Adjusted FCF per Share Chart

Cellectis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -1.72 -1.80 -1.83 -1.62

Cellectis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.83 -1.74 -1.74 -1.64 -1.62

Competitive Comparison of Cellectis's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Cellectis's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellectis's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectis's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cellectis's Cyclically Adjusted Price-to-FCF falls into.


;
;

Cellectis Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cellectis's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.018/119.9500*119.9500
=-0.018

Current CPI (Dec. 2024) = 119.9500.

Cellectis Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -0.136 100.170 -0.163
201506 -0.532 100.440 -0.635
201509 -0.154 99.950 -0.185
201512 0.788 100.040 0.945
201603 -0.844 100.020 -1.012
201606 -0.363 100.630 -0.433
201609 -0.123 100.340 -0.147
201612 0.015 100.650 0.018
201703 -0.477 101.170 -0.566
201706 -0.334 101.320 -0.395
201709 -0.453 101.330 -0.536
201712 -0.279 101.850 -0.329
201803 -0.572 102.750 -0.668
201806 -0.310 103.370 -0.360
201809 -0.383 103.560 -0.444
201812 -0.544 103.470 -0.631
201903 -0.570 103.890 -0.658
201906 -0.571 104.580 -0.655
201909 -0.662 104.500 -0.760
201912 -0.130 104.980 -0.149
202003 -0.153 104.590 -0.175
202006 -0.852 104.790 -0.975
202009 -0.752 104.550 -0.863
202012 -1.175 104.960 -1.343
202103 -1.146 105.750 -1.300
202106 -0.387 106.340 -0.437
202109 -0.789 106.810 -0.886
202112 -0.451 107.850 -0.502
202203 -0.819 110.490 -0.889
202206 -0.543 112.550 -0.579
202209 -0.586 112.740 -0.623
202212 -0.032 114.160 -0.034
202303 -0.555 116.790 -0.570
202306 -0.377 117.650 -0.384
202309 -0.284 118.260 -0.288
202312 0.603 118.390 0.611
202403 -0.229 119.470 -0.230
202406 0.569 120.200 0.568
202409 -0.066 119.560 -0.066
202412 -0.018 119.950 -0.018

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Cellectis  (NAS:CLLS) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Cellectis Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Cellectis's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cellectis Business Description

Industry
Address
8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.